XP

Xincheng Private Equity

Description

Xincheng Private Equity is a private securities investment fund manager.

Investor Profile

Xincheng Private Equity has made 3 investments, with 2 in the past 12 months and 0% as lead.

Stage Focus

  • Series A (67%)
  • Seed (33%)

Country Focus

  • China (100%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Pharmaceutical
  • Life Science
  • Health Care
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Xincheng Private Equity frequently co-invest with?

GSR United Capital
Asia, Beijing, China, Beijing
Co-Investments: 1
Haiwang Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 1
Cathay Capital
Europe, Ile-de-France, France, Paris
Co-Investments: 1
Co-Investments: 2
Co-Investments: 1
Asymchem Laboratories (Tianjin)
Asia, Guangdong, China, Tianjin
Co-Investments: 1
CC
Asia, Liaoning, China, Chaoyang
Co-Investments: 1
Sino Biological
Asia, Beijing, China, Beijing
Co-Investments: 1

What are some of recent deals done by Xincheng Private Equity?

Enokiko

Pudong, Shandong, China

Enokiko is a provider of synthetic biology platforms oriented to the study, & manufacturing of environmentally friendly biological products.

BiopharmaBiotechnologyMedical
Series AMar 3, 2025
Amount Raised: $20,589,971
Rigerna

Fengtai, Beijing, China

Rigerna develops unique small nucleic acid medicines and innovative nucleic acid therapies for nonliver tissues.

BiopharmaHealth CarePharmaceutical
SeedOct 21, 2024
Amount Raised: $14,046,917
Bio-Link

Shanghai, Shanghai, China

Bio-Link is a drug development company that offers solutions for the life science industry.

BiopharmaBiotechnologyLife SciencePharmaceutical
Series AFeb 21, 2024